Using the Plasmodium mitochondrial genome for classifying mixed-species infections and inferring the geographical origin of P. falciparum parasites imported to the U.S

PLoS One. 2019 Apr 30;14(4):e0215754. doi: 10.1371/journal.pone.0215754. eCollection 2019.

Abstract

The ability to identify mixed-species infections and track the origin of Plasmodium parasites can further enhance the development of treatment and prevention recommendations as well as outbreak investigations. Here, we explore the utility of using the full Plasmodium mitochondrial genome to classify Plasmodium species, detect mixed infections, and infer the geographical origin of imported P. falciparum parasites to the United States (U.S.). Using the recently developed standardized, high-throughput Malaria Resistance Surveillance (MaRS) protocol, the full Plasmodium mitochondrial genomes of 265 malaria cases imported to the U.S. from 2014-2017 were sequenced and analyzed. P. falciparum infections were found in 94.7% (251/265) of samples. Five percent (14/265) of samples were identified as mixed- Plasmodium species or non-P. falciparum, including P. vivax, P. malariae, P. ovale curtisi, and P. ovale wallikeri. P. falciparum mitochondrial haplotypes analysis revealed greater than eighteen percent of samples to have at least two P. falciparum mitochondrial genome haplotypes, indicating either heteroplasmy or multi-clonal infections. Maximum-likelihood phylogenies of 912 P. falciparum mitochondrial genomes with known country origin were used to infer the geographical origin of thirteen samples from persons with unknown travel histories as: Africa (country unspecified) (n = 10), Ghana (n = 1), Southeast Asia (n = 1), and the Philippines (n = 1). We demonstrate the utility and current limitations of using the Plasmodium mitochondrial genome to classify samples with mixed-infections and infer the geographical origin of imported P. falciparum malaria cases to the U.S. with unknown travel history.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • DNA, Protozoan / genetics
  • Epidemiological Monitoring
  • Genome, Mitochondrial*
  • Genome, Protozoan*
  • Haplotypes
  • High-Throughput Nucleotide Sequencing
  • Humans
  • Malaria / epidemiology
  • Malaria / parasitology*
  • Malaria, Falciparum / epidemiology
  • Malaria, Falciparum / parasitology
  • Phylogeography
  • Plasmodium / classification
  • Plasmodium / genetics*
  • Plasmodium / pathogenicity
  • Plasmodium falciparum / classification
  • Plasmodium falciparum / genetics*
  • Plasmodium falciparum / pathogenicity
  • Polymorphism, Single Nucleotide
  • Travel
  • United States / epidemiology

Substances

  • DNA, Protozoan

Grants and funding

This work was made possible through support from the Advanced Molecular Detection (AMD) initiative at the CDC. We also acknowledge partial support from the CDC Antimicrobial Resistance Working Group and partial support by the Bioinformatics Fellowship Program administered by the Association of Public Health Laboratories (APHL) and funded by the CDC. S.E.S. is currently supported in part by the Bioinformatics Fellowship Program administered by the APHL and funded by the CDC. J.K. is currently supported in part by the Atlanta Research and Education Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Author Dhruviben Patel is employed by Williams Consulting LLC. Williams Consulting LLC provided support in the form of salary for author DP, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the ‘author contributions’ section.